Orphazyme Stock Gains After FDA Update On Arimoclomol In Rare Neurodegenerative Disorder
November 01, 2021 at 08:00 AM EDT
Orphazyme A/S(NASDAQ: ORPH) shares are moving higher afterproviding a regulatory updatefor arimoclomol in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.